dr. S. van den Hof

Research

Publications
  1. The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis

    Zhang, M., Wang, S., Wilffert, B., Tong, R., van Soolingen, D., van den Hof, S. & Alffenaar, J-W., Dec-2018, In : British Journal of Clinical Pharmacology. 84, 12, p. 2747-2760 14 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  2. Pharmacokinetics of Levofloxacin in Multidrug-and Extensively Drug-Resistant Tuberculosis Patients

    Boveneind - Vrubleuskaya ,van 't, N., Seuruk, T., van Hateren, K., van der Laan, T., Kosterink, J. G. W., van der Werf, T. S., van Soolingen, D., van den Hof, S., Skrahina, A. & Alffenaar, J-W. C., Aug-2017, In : Antimicrobial Agents and Chemotherapy. 61, 8, 10 p., ARTN e00343-17.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting

    Boveneind - Vrubleuskaya , van 't, N., Daskapan, A., Kosterink, J. G. W., Werf, van der, T., van den Hof, S. & Alffenaar, J-W. C., 10-Nov-2016, In : PLoS ONE. 11, 11, 12 p., e0166030.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (3) »

View graph of relations

ID: 39014618